Acytron-KD features an advanced dual-active formula combining N-acetyl L-cysteine (NAC) and Taurine, delivered via specialized Tablet-in-Tablet Technology. Formulated to slow down Chronic Kidney Disease (CKD) progression, it provides a complete therapeutic approach to delay the onset of End-Stage Renal Disease (ESRD). The synergistic formulation targets the root drivers of renal decline by drastically mitigating oxidative stress, preserving vulnerable renal microvasculature, suppressing critical inflammatory mediators, and maintaining stable serum creatinine and eGFR levels to optimize remaining kidney function.
N-acetyl L-cysteine + Taurine
1*1*10 Tablets/Strip
Usage: Management of Chronic Kidney Disease Progression.
Dosage: As directed by your healthcare professional.
Generally well tolerated when taken as prescribed. Consult your physician if any unwanted effects occur.
